![]() |
|
|||||||
![]() |
||||||||
Mid Term Strategy
|
|
Announcing: NewOrgan Prize
Our newest prize will be awarded to the first research team who successfully construct and transplant a whole new organ made from a patient's own cells. The Latest in a Series of Initiatives |
|
| Again Methuselah Foundation has taken the lead in supporting and inspiring scientific breakthroughs to extend the healthy lifespan. To accelerate and publicize the work in tissue engineering - a key component of Strategies for Engineered Negligible Senecence (SENS) - we have established the NewOrgan Prize. To win this prize for creating immune identical replacement organs, scientists must also develop all the tissues that build organs including muscle, nerves, arteries and veins. The impact that this will have on extending healthy human life is certain to be extremely significant. We will keep you up to date on the breakthroughs as they happen. |
Methuselah Foundation took on a big challenge: extending healthy human life. From SENS to My Bridge 4 Life,
we've supported and incentivized major initiatives and research to fulfill our mission. In 2010 we are
focusing our attention on tissue and whole organ engineering.
Read »
We are very pleased to announce the addition of two new Mprize competitors, Alan Cash and Holly Brown Borg. Both are
investigating metabolic pathways of longevity derived from calorie restriction research.
Read »
Silverstone Solutions matchmaking technology for organ transplants is demonstrated in the Bay Area,
arranging complicated chains of donors and transplants - opportunities that might otherwise have slipped by.
Read »
Welcome to a network created just for you. If you or someone you know needs an organ join the NewOrgan Network today.
Methuselah Foundation is co-sponsoring its first near-term strategy: My Bridge 4 Life™. If you or someone you care about is facing a life-threatening health challenge, then My Bridge 4 Life™ is here to help. Build a Bridge Plan now!
Organovo is a regenerative medicine company that applies propietary technology to "print" new organs. Their work will enable us to quickly and cheaply produce organs and body tissues for transplantation and testing.